In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur.
Disposal of Zostavax®
Zostavax® vaccine will no longer be provided on the NIP from 1 November 2023. Immunisation providers may continue to administer Zostavax® for people aged 70 years old who prefer to receive this vaccine until they expire in 2024.
If there is no patient demand, providers may discard Zostavax® vaccines prior to expiry date. Report discarded quantity in the NSW Vaccine Centre portal > Report Expired Vaccines, and input expiry date as 1 November 2023.
New mandatory AIR reporting fields
Two new reporting fields have been added to the Australian Immunisation Register (AIR), and from 1 March 2024 these reporting fields will become mandatory.
Under the ‘vaccine type’ field, providers will be able to choose from 4 vaccine types: Antenatal, NIP/Commonwealth, Private, or State Program. Only one option can be selected under the ‘vaccine type’ field.
The Antenatal option should be selected when the person presenting is pregnant at the time the vaccine is administered, regardless of whether the vaccine is funded privately, under the NIP or a state and territory program. COVID-19 vaccines should be reported as NIP/Commonwealth.
Route of administration
The ‘route of administration’ field will only be mandatory for Japanese encephalitis vaccines. Under the ‘route of administration’ field, providers will be able to choose from: Oral, Subcutaneous, Intradermal, or Intramuscular.
New AIR043A report
The new AIR043A Vaccine Details report is available for vaccination providers through the AIR site.
This report can be used by vaccination providers to extract and reconcile vaccination information that they have previously reported to the AIR. The report contains information about the individual that they have vaccinated and the vaccine details (such as the vaccine brand, vaccine type and route of administration).
Further information about the AIR043A report is available on the Services Australia website.
NIP vaccinations in pharmacy (NIPVIP)
The National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program will commence 1 January 2024.
This program allows eligible patients to access free National Immunisation Program (NIP) vaccines in a community pharmacy, with no out-of-pocket costs. More information available here.
COVID-19 Digital Certificate decommissioned
The COVID-19 Digital Certificate has been decommissioned and the COVID-19 and Influenza Immunisation History Statement (IHS) can now be used for the purpose of proof of vaccination.
This statement can be saved to digital wallets (Apple/Google) to enable easy access. Further information about the IHS and proof of vaccination is available on the Services Australia website.
New COVID-19 vaccines target current variants
The Australian Government has approved the use of new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program.
The new XBB 1.5 vaccines have been found to provide modest improved protection against the COVID-19 strains circulating in the community. The XBB 1.5 vaccines will be available along with the existing bivalent vaccines.
There is no change to current vaccine eligibility recommendations.
The new vaccine is a good reminder for people to get vaccinated if they haven’t had their recommended dose(s) in 2023.
Handbook COVID-19 chapter was updated to reflect the current preference for the use of Omicron XBB.1.5 vaccines in primary courses and as further doses to better target current circulating COVID-19 variants.
Immunisation Weekly Update State Vaccine Centre Christmas closure The State Vaccine Centre will no longer be accepting vaccine orders. Orders placed before midday Tuesday, 19 December will be dispatched Wednesday, 20 December, and routine deliveries will recommence on Tuesday, 2 January 2024. Please do not order excessive stock over this…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: International Shingrix stock The NSW State Vaccine Centre have begun distributing internationally branded stock of Shingrix vaccines, approved under section 19A of the Therapeutic goods Act 1989. Immunisation providers are advised to note the differences from the Australian branded stock, particularly the US date format: MM/DD/YYYY. The…
Immunisation Weekly Update: Immunisation webinars Register for upcoming immunisation education webinars. View past webinar recordings on our Immunisation | Education webpage. Webinar: RSV in infants REGISTERThis webinar will provide an update on respiratory syncytial virus (RSV) and explore next steps for RSV vaccines and treatments for infants. Date: Tuesday 27…
Immunisation Weekly Update: Webinar: NSW influenza program 2024 Register for the annual NSW Health Influenza Vaccination Program webinar to receive information on the 2024 flu vaccination program. About: NCIRS specialist paediatrician will present on 2024 influenza vaccines and their use in eligible age groups, and strategies to increase uptake in…
Immunisation Weekly Update: Register for 2024 Immunisation update event Join us online for CESPHN’s annual immunisation update presented by NCIRS. This webinar will cover the latest clinical information on RSV (respiratory syncytial virus), influenza, COVID-19, emerging diseases, and more. When: Thursday 14 March 2024 Time: 7.00pm to 8.30pm Register Measles…